GLP-1s for Alcohol Use Disorder (AUD) Early research has included investigations to determine whether GLP-1 might be an effective treatment for AUD
These effects result in very significant weight loss (15-20% of initial body weight), i.e., of the same order of magnitude as that obtained by bariatric surgery
Generally, lidocaine is quite safe when applied topically and has very few side effects, including mild itching or redness at the application site
The SCALE (Satiety and Clinical AdiposityLiraglutide Evidence) study comprised a series of Phase 3 trials evaluating the efficacy of Liraglutide 3 mg in diverse populations, including general obese patients, as well as those with pre-diabetes, diabetes, and sleep apnea syndrome 10,11,12,13,14,15
Clinical evidence The 2013 exenatide proof-of-concept clinical trial involving 45 moderate PD patients displayed possible efficacy concerning part 3 of the Movement Disorders Society Unified Parkinsons Disease Rating Scale (MDS-UPDRS) [17]
Many dogs show noticeable improvement in energy and stool consistency within the first two to four weeks of starting injections
